AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05569577 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: estrogen and dydrogesterone
Description: estrogen and dydrogesterone
Study NCT05569577 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: estrogen and dydrogesterone
Description: estrogen and dydrogesterone
Study NCT05632497 — intervention group
Intervention type: BIOLOGICAL
Intervention: Stool and blood samples
Description: Stool and blood samples
Study NCT06253260 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Analgesic Efficacy of Sequential Slow Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine in Patients Undergoing Unilateral Inguinal Hernia Repair Surgery
Description: Analgesic Efficacy of Sequential Slow Intrathecal Injection Of Dexmedetomidine Followed by Slow Injection of Hyperbaric Bupivacaine in Patients Undergoing Unilateral Inguinal Hernia Repair Surgery
Study NCT06627075 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Surface Guided RadioTherapy (SGRT) without mask
Description: Firstly, patients are positioned in a vacuum mattress that moulds their head, neck and shoulders for a reference scan.~During the treatment sessions, patients are positioned according to the reference scan, using the surface camera system.~Once the observed offsets have been applied, the patient's surface is captured. Treatment can then begin, with continuous monitoring of displacements by the surface camera system. Automatic beam interruption is provided during treatment in the event of motion detection exceeding the standard tolerance threshold (>3 mm).~If the use of a thermoformed mask during your treatment prove necessary, for whatever reason, will not result in a halt to the research.~Patients receive between 10 and a max of 35 radiotherapy sessions. The follow-up period begins after the last radiotherapy session, and patients are assessed at 4 or 6 weeks and at 3 months by a radiotherapist.
Study NCT06628232 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pacifier with breast milk
Description: swaddling in the mother\&#39;s lap together with giving a pacifier dipped in breast milk
Study NCT06628232 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: heel heating
Description: swaddling in the mother\&#39;s lap together with local dry heat application
Study NCT06143579 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FOLFOX-HAIC+Lenvatinib+Envolizumab
Description: FOLFOX-HAIC: Oxaliplatin 130 or 85 mg/m2; leucovorin 200 mg/m2; fluorouracil 400 mg/m2 intravenous bolus followed by fluorouracil 2400 mg/m2 continuous infusion over 23 hours, Q3W, 2 to 4 cycles;~Lenvatinib: 8 mg/day (BW \< 60 kg) or 12 mg/day (BW ≥ 60 kg), PO, 3-4 cycles;~Envolizumab: 300 mg, SC, Q3W, 3-4 cycles.
Study NCT05760456 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DIDALA hard capsules
Description: DIDALA is given orally with a dose of 2 capsules, 3 times per day for 12 weeks
Study NCT05760456 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: Metformin 500mg, 1 tablet twice a day, immediately after breakfast and dinner for 12 weeks
Study NCT06628232 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: interventions combined
Description: swaddling in the mother\&#39;s lap together with giving a pacifier dipped in breast milk and heel heating
Study NCT06628232 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: swaddling the baby in the mother\&#39;s lap
Study NCT06255145 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Bioelectrical Impedance Analysis
Description: Bioelectrical Impedance Analysis Beurer BF 1000 Super Precision device was used to measure the body composition of the participants. Operating on the principle of BIA, the device allows the body composition to be evaluated by giving an imperceptible electric current to the body.~Fatigue Severity Scale (FSS) Fatigue Severity Scale (FSS) was used to measure participants' fatigue levels. Rivermead Mobility Index Rivermead Mobility Index (RMI) was used to assess the mobility levels of the participants.~Functional Independence Measure Functional Independence Measure (FIM) was used to evaluate the functional status of the participants.
Study NCT06255145 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Bioelectrical Impedance Analysis
Description: Bioelectrical Impedance Analysis Beurer BF 1000 Super Precision device was used to measure the body composition of the participants. Operating on the principle of BIA, the device allows the body composition to be evaluated by giving an imperceptible electric current to the body.~Fatigue Severity Scale (FSS) Fatigue Severity Scale (FSS) was used to measure participants' fatigue levels. Rivermead Mobility Index Rivermead Mobility Index (RMI) was used to assess the mobility levels of the participants.~Functional Independence Measure Functional Independence Measure (FIM) was used to evaluate the functional status of the participants.
Study NCT06726993 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Total knee arthroplasty
Description: Total knee arthroplasty (TKA) is a common orthopaedic surgery that involves replacing the articular surfaces (femoral condyles and tibial plateau) of the knee joint with smooth metal and highly cross-linked polyethylene plastic
Study NCT06742736 — intervention group
Intervention type: DRUG
Intervention: BGF
Description: BUDESONIDE/GLYCOPYRRONIUM/FORMOTEROL
Study NCT06028477 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Stanford Glove
Description: The non-invasive neuromodulation hardware system comprises two wireless controllers/battery packs which are fastened to the top of each hand via an adjustable elastic strap. Each controller is equipped with four vibrotactile fingertip stimulators, also known as tappers. There is a total of eight tappers (for index, middle, ring and pinkie of each hand) per system.
Study NCT06028477 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Stanford Glove
Description: The non-invasive neuromodulation hardware system comprises two wireless controllers/battery packs which are fastened to the top of each hand via an adjustable elastic strap. Each controller is equipped with four vibrotactile fingertip stimulators, also known as tappers. There is a total of eight tappers (for index, middle, ring and pinkie of each hand) per system.
Study NCT05125042 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Amiodarone hydrochloride tablet + acupoint catgut embedding
Description: Patients with persistent AF after undergoing catheter ablation take receive acupoint catgut embedding in Neiguan and Zusanli twice after and one month after surgery combined with amiodarone hydrochloride tablets 200mg bid, 1 month; 200mg qd,maintained to 3 months.All patients, who had no signs of recurrence three months after surgery, stopped taking medication.
Study NCT06508567 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: High Dose Rate Brachytherapy
Description: 2 fractions of MRI-guided HDR Brachytherapy (13Gy each) delivered over 14 days (± 7 days).
Study NCT05971056 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Care transition
Description: Cancer care is transitioned to a satellite site.
Study NCT05971056 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No care transition
Description: Cancer care is not transitioned to a satellite site.
Study NCT05585385 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Backward Walking Training
Description: The subjects in this group will receive BW training program on an electric treadmill. The subject will be asked to walk, arms beside, in a backward manner on a level treadmill, zero inclination, with a warming up and cooling down period (5 minutes for each period). The subject walks at his self-selected and comfortable walking speed. A warm-up and cool-down period, in form of light jogging on a treadmill, will be done at speed of 1-2 m/sec. The total training is 30 minutes, three times a week for six consecutive weeks.
Study NCT05125042 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amiodarone hydrochloride tablet
Description: Patients with persistent AF after undergoing catheter ablation only take amiodarone hydrochloride tablets 200mg bid, 1 month; 200mg qd,maintained to 3 months.All patients, who had no signs of recurrence three months after surgery, stopped taking medication.
Study NCT05125042 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amiodarone hydrochloride tablet
Description: Patients with persistent AF after undergoing catheter ablation only take amiodarone hydrochloride tablets 200mg bid, 1 month; 200mg qd,maintained to 3 months.All patients, who had no signs of recurrence three months after surgery, stopped taking medication.
Study NCT04410653 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afatinib 40 MG
Description: single oral dose of afatinib each day starting at a dose of 40 mg on day 1, continuously, until the development of progressive disease or unacceptable adverse events
Study NCT05758623 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Device
Description: The experimental group was treated with magnesium containing biodegradable polymer bone repair material produced by Shenzhen Zhongke Jingcheng Medical Technology Co., Ltd. Control group application β- Tricalcium phosphate bioceramics for treatment.
Study NCT05585385 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Balance Training
Description: Subjects in this group will receive balance training on Biodex Balance System for 3 sessions/ week, over 6 weeks period. Each subject will be instructed to stand with both legs on the locked platform. The researcher advances the platform to an unstable state while instructing the subject to focus on the visual feedback screen. Arms are free at the side of the body and not grasping handrails.~After selecting the stability training program (dynamic balance training), Stability levels are changed depending on the subject's ability to maintain balance, and subjects are instructed to maintain their Center of Pressure (COP) in the smallest concentric rings (balance zones) of the Biodex Balance System monitor, named A zone.~The stability level of the platform is set at level plate stability 8 (the most stable) for the first two sessions. After that, the plate stability is decreased by one level every two sessions to increase the difficulty in training.
Study NCT05585385 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: Patients in this group will receive the traditional physical therapy program only for 3 sessions/ week, over 6 weeks period. The traditional physical therapy program is (evertors strengthening, short foot ex, heel raise ex, and calf stretch).
Study NCT04705298 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Prebiotic
Description: Oligofructose-enriched inulin. 4 grams daily for ≤ age 6; or 8 grams daily for >6 years
Study NCT04705298 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin 4 grams daily for ≤ age 6; or 8 grams daily for >6 years
Study NCT06527651 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Genicular blocks (dexamethazone and lidocaine)
Description: Genicular blocks were applied bilaterally by another physiatrist who was experienced in ultrasonographic (US) interventional procedures more than 5 years. Total of 6mL solution consisting of 0.5 mg/2mL dexamethazone and 4mL %1 lidocaine for three branches of genicular nerves (superomedial, superolateral and inferomedial branches) was divided into three branches for each knee. Total of 12 mL solution was applied for each patient.
Study NCT05719285 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Single-Dose Antibiotic
Description: Allergy, prior urine culture resistance or another contraindication to first line antibiotic will result in the patient being prescribed second line antibiotic and so forth.~First line:~Arm 1: trimethoprim / sulfamethoxazole 800/160 mg once pre-procedure~Second line:~Arm 1: cefalexin 500 mg once pre-procedure~Third line:~Arm 1: nitrofurantoin 100 mg once pre-procedure~Fourth line:~Arm 1: ciprofloxacin 500 mg once pre-procedure
Study NCT04188366 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FAMES
Description: Participants will receive three distinct and revolving components - early, continuous, and motivational contact - that incorporate motivational techniques and the Diagnostic and Statistical Manual of Mental Disorders 5TH Edition (DSM-5) Cultural Formulation Interview (CFI).
Study NCT04188366 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Treatment-as-Usual
Description: Participants will receive usual services and family-based treatment offered
Study NCT05176561 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Auditory-Cognitive Training
Description: Treatment Participants will complete 8 weeks of training for 2 hours per week and participate in a 1 hour meeting with clinician. Participants with spend 1 hour auditory training use Angel Sound and one hour of auditory cognitive training using auditory portions of Posit Science. A clinical paradigm including reviewing results, providing strategies and positive feedback and strategies in the 1 hour virtual meeting of clinician and participant. Practice for next week is assigned.~Control group intervention follows the same time and procedure but the materials are non-auditory puzzles (Sudoku, Cross Word Puzzles, Spot the Difference, Ken-Ken and Word Search).
Study NCT05176561 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Non-auditory Cognitive Training
Description: Participant will complete 8 weeks of training for 2 hours per week and participate in a 1 hour meeting with clinician. Control group intervention follows the same time and clinical paradigm, but the materials are non-auditory puzzles (Sudoku, Cross Word Puzzles, Spot the Difference, Ken-Ken and Word Search).
Study NCT04422795 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: External thermomechanical device delivering cold and vibration stimuli
Description: the thermomechanical device will be placed on the digit 2 cm proximally to the injection site with the ice wings frozen and the vibration mechanism switched on, delivering vibration and cold stimuli to the area for 30 seconds before the intramatricial injection and until needle withdrawal
Study NCT04422795 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: External thermomechanical device without delivering cold and vibration stimuli
Description: the thermomechanical device will be placed on the digit 2 cm proximally to the injection site with the ice wings at unfrozen and the vibration mechanism switched off, for 30 seconds before the intramatricial injection and until needle withdrawal
Study NCT04422795 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ethyl chloride skin refrigerant spray
Description: Ethyl chloride skin refrigerant spray is applied to the area of injection for 3 seconds immediately before needle insertion
Study NCT05384704 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Empower@Home
Description: The intervention is a 9-week course of internet-based cognitive behavioral therapy. During the active intervention phase, participants will receive weekly support from a trained research staff.
Study NCT05370456 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Local application of a HA gel for the treatment of MAGRs with mCAF technique and XCM
Description: After local anaesthesia, mCAF technique with two releasing vertical incisions will be performed. XCM will be adapted on the root surfaces and positioned at the level of the cemento-enamel junction and HA gel will be applied.
Study NCT05370456 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Treatment of MAGRs with mCAF technique and XCM
Description: After local anaesthesia, mCAF technique with two releasing vertical incisions will be performed. XCM will be adapted on the root surfaces and positioned at the level of the cemento-enamel junction.
Study NCT05719285 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Multi-Dose Antibiotic
Description: Allergy, prior urine culture resistance or another contraindication to first line antibiotic will result in the patient being prescribed second line antibiotic and so forth.~First line:~Arm 2: trimethoprim / sulfamethoxazole 800/160 mg once pre-procedure plus 800/160 mg every twelve hours for 6 total doses~Second line:~Arm 2: cefalexin 500 mg once pre-procedure plus 500 mg every twelve hours for 6 total doses~Third line:~Arm 2: nitrofurantoin 100 mg once pre-procedure plus 100 mg every twelve hours for 6 total doses~Fourth line:~Arm 2: ciprofloxacin 500 mg once pre-procedure plus 500 mg every twelve hours for 6 total doses
Study NCT05324176 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: diaphragmatic ultrasound
Description: diaphragmatic thickness will be measured on both sides during a deep breath in inspiration and during expiration.
Study NCT05337930 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Happyr App
Description: The Happyr app offers three main areas:~(A) A mood diary in which a user can keep track of emotional wellbeing by answering three short questions.~(B) A pain diary in which a user and supporter can record headache attacks by answering a set of predefined questions whenever a user experiences or has experienced a headache attack.~(C) An overview section in which entries from the mood and pain diary are visualized for the user. In this section, a PDF document can also be exported with a summary of data from the symptom diary that can be taken to the clinician.~A standardized notification is sent to each user at 6pm local time to remind them about logging their mood and symptoms of a headache attack.
Study NCT05509946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Single dose of celecoxib 400 mg and pregabalin 150 mg
Description: Single dose of celecoxib 400 mg and pregabalin 150 mg
Study NCT05509946 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Repeated dose of celecoxib 200 mg and pregabalin 75 mg
Description: Repeated dose of celecoxib 200 mg and pregabalin 75 mg started 3 days before surgery
Study NCT05509946 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05800457 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Partial synovectomy
Description: Patients in the intervention group will undergo partial synovectomy during total knee replacement surgery
Study NCT04472091 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Genicular artery embolization (GAE)
Description: Participants will undergo GAE with HydroPearl® Microspheres (polyethylene glycol microspheres, Terumo Medical, Somerset NJ).
Study NCT04994535 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OnabotulinumtoxinA
Description: Injection
Study NCT04994535 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline injection
Study NCT06562504 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS)- anodal group
Description: 2mA/20mins/session;
Study NCT06562504 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS)- sham group
Description: 0mA/20mins/session
Study NCT06562504 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: transcranial alternating current stimulation (tACS)-tACS group
Description: 1.5 mA/20 min/session; 6HZ, theta
Study NCT06013150 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Epinephrine
Description: Participants in Part 1 of the study will receive single dose either 1mg, 1.3mg or 1.5mg of an inhaled single dose of Epinephrine or placebo delivered via DMC-IHI device.
Study NCT06013150 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Epinephrine
Description: Participants in Part 1 of the study will receive single dose either 1mg, 1.3mg or 1.5mg of an inhaled single dose of Epinephrine or placebo delivered via DMC-IHI device.
Study NCT06013150 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participant in Part 1 of the study will receive matching doses of placebo
Study NCT06013150 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participant in Part 1 of the study will receive matching doses of placebo
Study NCT05577468 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tegoprazan
Description: tegoprazan-containing bismuth quadruple therapy or Esomeprazole-containing bismuth quadruple therapy; Route of administration: oral;
Study NCT05577468 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tegoprazan
Description: tegoprazan-containing bismuth quadruple therapy or Esomeprazole-containing bismuth quadruple therapy; Route of administration: oral;
Study NCT06258473 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Multicomponent decentralized care
Description: 1. Training and support on Simple app for HTN/DM management \& training NCD corner clinicians on clinical guidelines and establish team-based care for Upazila level NCD corner~2. CHCPs conduct BP/BG screening, monitoring, lifestyle counseling, dispensing of medications, follow-up overdue patients at CCs \& CHCP care coordination supported by Simple app at community clinics~3. CHWs assist in screening, counselling, referral, and follow-up for CHW at village level
Study NCT06653634 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methotrexate
Description: Gradual withdrawal of the medication
Study NCT06653634 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methotrexate
Description: Gradual withdrawal of the medication
Study NCT06258473 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: mHealth
Description: Training and support on Simple app for HTN/DM patient management \& training NCD corner clinicians on clinical guidelines of Upazila Health complex
Study NCT06653634 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: TNF Inhibitor
Description: Gradual withdrawal of the medication